Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Virginia: The Complete Guide for Women, Families, and Survivors
For women in Virginia who have undergone breast reconstruction following a mastectomy, or those who chose cosmetic augmentation or a mastopexy “internal bra” procedure, the journey toward healing is supposed to be one of restoration. Whether you sought care at a major academic institution like the VCU Medical Center in Richmond, the UVA Health system in Charlottesville, or a private surgical suite in Northern Virginia or Virginia Beach, you trusted that the materials implanted in your body were vetted for safety. We understand the profound sense of betrayal you feel when you learn that the surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffold used in your surgery may have never been cleared by the FDA for that specific use.
If you are currently experiencing persistent redness, unexplained swelling, chronic pain, or the devastating loss of a reconstruction you fought hard to achieve, we know that your life has been interrupted by a medical crisis you did not create. We recognize that the women of Virginia—from the bustling corridors of Alexandria to the coastal communities of Hampton Roads—deserve more than just a lawyer; they deserve a legal team that understands the high-science pathology of these injuries and the regulatory failures that allowed these devices into Virginia operating rooms. At The Manginello Law Firm, PLLC, known to many as Attorney911, we bring twenty-seven years of continuous legal practice and a deep substantive command of federal medical device litigation to your side.
Ralph P. Manginello and Lupe Peña serve as your advocates, combining a sophisticated understanding of product liability with the compassionate authority a case of this gravity demands. With Ralph Manginello’s admission to the United States District Court for the Southern District of Texas and the firm’s lead role in high-stakes institutional litigation—such as the recent $10 million Bermudez v. Pi Kappa Phi fraternity hazing lawsuit—we demonstrate the structural capability to prosecute complex multi-defendant cases against massive device manufacturers. For our Spanish-dominant neighbors in Virginia’s diverse communities, Lupe Peña provides the direct, bilingual representation necessary to ensure that no patient is silenced by a language barrier during their pursuit of justice.
Understanding the Devices: ADM, Scaffolds, and Mesh in Virginia Breast Surgery
To handle a medical device injury case in Virginia, a legal team must first understand exactly what was placed inside your body. Many surgeons in Virginia surgical centers utilize three primary categories of supplemental materials to support breast implants or tissue expanders. These products are often marketed to physicians as tools to create a better aesthetic “pocket” or to provide additional strength to the lower pole of the breast.
Acellular Dermal Matrix (ADM)
Acellular dermal matrix is a biological material, typically derived from human cadavers or porcine (pig) skin. The manufacturing process involves stripping the donor tissue of its cells—the parts that would trigger a rejection response—leaving behind a “scaffold” of collagen and proteins. Brands frequently used in Virginia include AlloDerm (Allergan/AbbVie), Strattice, FlexHD (MTF Biologics), and AlloMax (Becton Dickinson). While marketed as a natural way to support reconstruction, these biological grafts can carry bacterial endotoxins that the body recognizes as foreign, leading to a specific inflammatory response known as Red Breast Syndrome.
Bioabsorbable Scaffolds
Unlike permanent mesh, bioabsorbable scaffolds are synthetic materials designed to slowly dissolve as your body replaces the device with its own natural tissue. The most prominent product in this category is GalaFLEX, manufactured by Tepha and Galatea Surgical, both subsidiaries of Becton Dickinson (BD). GalaFLEX and the Phasix mesh line are composed of poly-4-hydroxybutyrate (P4HB). Although these are marketed to Virginia surgeons for their “internal bra” strengthening properties, significant questions have been raised about whether they resorb on the timeline the manufacturers claim, and whether they increase the risk of serious infection or cancer recurrence.
Synthetic Surgical Mesh
Standard synthetic mesh, often made of polypropylene, is sometimes used off-label in Virginia for breast procedures. These are similar to the materials used in the catastrophic transvaginal mesh and hernia mesh litigations. Because these surfaces are often textured or porous, they provide an ideal environment for bacterial biofilms to grow, which can lead to chronic inflammation and, in the most severe cases, rare forms of cancer like BIA-ALCL.
The FDA Regulatory Failure: Why Virginia Patients Weren’t Warned
Most patients in Virginia are shocked to learn that the mesh or ADM used in their breast surgery was never actually “FDA Approved” for use in the breast. Instead, these devices typically reached the market through the 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807 Subpart E, a manufacturer only needs to show that their new device is “substantially equivalent” to a “predicate” device already on the market.
This creates a dangerous phenomenon known as “predicate creep.” For example, the manufacturer of GalaFLEX cited a surgical suture as one of its predicate devices to get its mesh cleared for “soft tissue reinforcement.” By the time these products reached surgeons at major Virginia hubs like Inova Fairfax or Sentara Norfolk General, they were being used in the breast without ever having undergone rigorous pre-market clinical trials for that specific anatomical site.
In a landmark letter dated November 9, 2023, the FDA issued a safety communication explicitly stating: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This letter named the BD products—Phasix and GalaFLEX—and required labeling updates to reflect that they are not cleared for breast reconstruction. At The Manginello Law Firm, we believe that if the manufacturers had been transparent about this lack of data ten years ago, many Virginia women would have chosen a different path.
The Clinical Reality: Complications Faced by Virginia Women
The spectrum of injuries associated with defective breast mesh and scaffolds is broad and often requires multiple, painful revision surgeries. We monitor the peer-reviewed clinical literature and the MAUDE (Manufacturer and User Facility Device Experience) database under 21 CFR Part 803 to track the rising frequency of these complications among Virginia patients.
Red Breast Syndrome (RBS) and Sterile Inflammation
Red Breast Syndrome is a non-infectious inflammatory reaction specific to ADM products like AlloDerm or FlexHD. It presents as a bright red, often painful erythema on the breast skin, mimicking a severe infection. Scientific studies, such as those published by Nguyen et al., suggest that this is caused by high levels of bacterial endotoxins—lipopolysaccharides—that survive the sterilization process. For a woman in Virginia who has already survived cancer, the appearance of this redness causes immense psychological trauma, as it is often mistaken for a recurrence or a life-threatening infection.
BIA-ALCL and BIA-SCC: The Cancer Connection
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a CD30-positive, ALK-negative T-cell lymphoma that grows in the fluid and scar tissue around textured implants. The World Health Organization (WHO) recognized BIA-ALCL as a distinct malignancy in 2016. Furthermore, a newer threat has emerged: Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). In March 2023, the FDA updated its safety communications regarding SCC in the implant capsule. For Virginia patients, these diagnoses transform a reconstructive journey into a second fight for their lives, often involving the Allergan BIOCELL MDL 2921 litigation currently pending in federal court.
Reconstruction Failure and “Bottoming Out”
If you received a GalaFLEX or Phasix scaffold to support the lower pole of your breast and found that the breast eventually sagged or the scaffold remained palpable as a hard, sharp edge years later, you are experiencing a mechanical failure. When these devices fail to resorb as promised under the specific hydrolysis kinetics of breast tissue, they can erode through the skin or cause the entire reconstruction to fail, leaving many Virginia women to face a “flat closure” after their goals for symmetry were destroyed.
The Whistleblower Exposure: BD and GalaFLEX
The litigation in Virginia is informed by the courageous testimony of whistleblowers like Dr. Hooman Noorchashm. A cardiothoracic surgeon and former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was reportedly terminated in 2022 after raising serious safety concerns regarding GalaFLEX. His allegations are grave: he asserts that BD knew of breast cancer recurrences in patients who received GalaFLEX during clinical trials and failed to report these findings adequately to the FDA or the medical community.
Dr. Noorchashm’s record highlights the systemic failure of Medical Device Reporting (MDR) compliance. When a manufacturer suppresses adverse event data, they rob Virginia surgeons of the ability to provide true informed consent. At Attorney911, we investigate these layers of corporate concealment to build a case for our clients that goes beyond simple medical error and addresses the root cause: corporate negligence.
Why The Manginello Law Firm is the Logical Choice for Virginia Cases
Navigating a defective medical device claim in Virginia requires a firm that can bridge the gap between complex federal regulations and the practical realities of a patient’s life. Ralph Manginello and Lupe Peña offer a level of technical and doctrinal command that generalist personal injury firms cannot match.
- Federal Court Fluency: Cases involving the Allergan BIOCELL MDL 2921 or the emerging GalaFLEX litigation often land in the federal judicial system. Ralph Manginello is admitted to the United States District Court for the Southern District of Texas and has practiced for twenty-seven years, ensuring that we are prepared for the “Rocket Docket” speeds and rigorous Daubert evidentiary standards common in Virginia’s federal districts.
- Bilingual Capacity with Lupe Peña: Virginia’s patient population increasingly includes Spanish speakers who deserve to hear their legal options in their native tongue. Lupe Peña conducts full consultations in Spanish, removing the need for interpreters and ensuring that the nuances of your medical history and pain are never lost in translation.
- High-Profile Litigation Experience: Our firm is currently lead counsel in Bermudez v. Pi Kappa Phi, a $10,000,000 litigation that resulted in significant institutional changes. We treat device manufacturers with the same level of aggressive scrutiny we apply to any large organization that harms the public.
- No Fee Unless We Recover: We operate entirely on a contingency fee basis. This means women in Virginia can pursue justice against billion-dollar entities like Becton Dickinson or Allergan without any upfront legal costs or hourly bills.
The Legal Landscape in Virginia: Statutes and Preemption
Filing a lawsuit in Virginia involves navigating specific state-law frameworks that can be trap-laden for the inexperienced.
The Statute of Limitations in Virginia
Under Virginia Code § 8.01-243, the statute of limitations for personal injury is generally two years from the date the injury is sustained. However, in medical device cases, the “discovery rule” can be complex. You may have had the device implanted five years ago, but only learned of its defect through the FDA’s November 2023 letter or a recent biopsy. Determining exactly when your “clock” started is critical, and we provide the investigative work to preserve your right to sue.
Navigating Federal Preemption
Manufacturers often try to dismiss cases by claiming “federal preemption” under the Riegel v. Medtronic (2008) precedent. However, because most ADM and scaffold products are 510(k) cleared rather than PMA (Premarket Approval) sanctioned, they do not enjoy the same shield. We utilize the Medtronic v. Lohr (1996) and the “parallel claim” exceptions to ensure your case survives these defense motions.
Damages and Recovery
In Virginia, we seek to recover for your past and future medical bills, the cost of revision surgeries, lost wages from your time in recovery, and non-economic damages for pain, suffering, and permanent disfigurement. While the emotional toll of losing a breast reconstruction cannot be quantified by a calculator, we work with life-care planners and vocational experts to ensure your demand reflects the true cost of the manufacturer’s failure.
Frequently Asked Questions for Virginia Patients
Is GalaFLEX actually cleared for breast reconstruction?
No. As of the FDA’s most recent communications in late 2023, no surgical mesh products, including GalaFLEX, have been studied or cleared specifically for use in breast reconstruction or augmentation.
I have a “Red Breast” but no infection. Do I have a case?
Potentially. Red Breast Syndrome is often a sign of a reaction to bacterial endotoxins in an ADM product. If this reaction led to the need for a revision surgery or the loss of an implant, the manufacturer may be liable for failing to provide a safe, sterile product.
What if my surgeon told me the mesh was the “standard of care”?
Surgeons often rely on the information provided by manufacturer sales representatives. If the manufacturer engaged in off-label promotion and failed to disclose the risks Dr. Noorchashm and others have identified, the liability rests with the manufacturer for misleading the medical community.
How do I find out what brand of mesh was used in my Virginia surgery?
You have a legal right to your medical records. We can assist you in requesting your operative report and your device implant log, which contains the Unique Device Identifier (UDI) and lot numbers for everything placed in your body.
Can I still sue if my surgery was at a hospital in Richmond but I now live in Arlington?
Yes. Jurisdiction is generally based on where the harm occurred or where the manufacturer does business. We handle the jurisdictional complexities of Virginia and federal venues on your behalf.
Preserving Your Evidence and Your Rights
If you suspect your reconstruction is failing or you have been diagnosed with an implant-associated lymphoma, the time to act is now. Evidence preservation is the cornerstone of a successful product liability claim. We advise all our Virginia clients to:
- Request All Records: Secure your full surgical files from the hospital or ambulatory surgery center.
- Save the Explanted Device: If you undergo a removal (explant) surgery, we can work with your surgeon to ensure the mesh, ADM, or scaffold is preserved as evidence rather than destroyed by the hospital’s pathology lab.
- Document Everything: Keep a journal of your symptoms, photograph any visible redness or swelling, and track all out-of-pocket medical expenses.
Ralph Manginello and the team at The Manginello Law Firm (Attorney911) are here to ensure that your voice is heard. Whether you are dealing with the fallout of a GalaFLEX breast lift or the diagnosis of a BIA-ALCL malignancy from a textured implant, you do not have to fight the insurance companies and device manufacturers alone.
Contact Attorney911 for a Free Consultation in Virginia
We believe that every woman in Virginia deserves to understand what happened to her body. Our firm provides a safe, confidential, and technically sophisticated environment to discuss your potential claim. We pride ourselves on the “Excellent” 8.2 Avvo rating held by Ralph Manginello and the Martindale-Hubbell recognition that reflects our standing in the legal community.
Lupe Peña is ready to speak with our Spanish-speaking clients today. Hablamos español y estamos aquí para ayudarle.
Don’t let a corporation’s choice to put profits before patient safety define your future health. Call us today at 1-888-ATTY-911 (1-888-288-9911) for a no-obligation, free consultation. Let us put our twenty-seven years of experience and our former insurance-defense insights to work for you. We serve clients across the entire Commonwealth of Virginia, and we are ready to listen to your story.
Disclaimer: This content is provided for educational purposes and does not constitute medical advice or a specific attorney-client relationship. Past results, including the Bermudez litigation, do not guarantee future outcomes. The Manginello Law Firm, PLLC, operates on a contingency fee basis—no fee unless we recover for you. Case expenses may apply.
